NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Phase 1

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 42

Registration Number: NCT00001644

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals

Completed

Conditions: Atopic Dermatitis
Healthy
Mastocytosis

First Posted Date: 1999-11-04

Last Posted Date: 2007-12-13

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 40

Registration Number: NCT00001760

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2019-12-16

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 38

Registration Number: NCT00001899

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes

Recruiting

Conditions: Granuloma
Genetic Disease, X-Linked
Genetic Disease, Inborn
Granulomatous Disease, Chronic
Leukocyte Disease

First Posted Date: 1999-11-04

Last Posted Date: 2024-12-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 850

Registration Number: NCT00001405

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses

Terminated

Conditions: Abnormal Phagocyte Function
Healthy Volunteers

First Posted Date: 1999-11-04

Last Posted Date: 2019-08-06

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 169

Registration Number: NCT00001257

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Study of Patients With Strongyloides Stercoralis Infection

Completed

Conditions: HIV Infection
Nematode Infection
Strongyloidiasis

First Posted Date: 1999-11-04

Last Posted Date: 2009-08-25

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 650

Registration Number: NCT00001245

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Drug Interactions Among Anti-HIV Agents

Phase 1

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 22

Registration Number: NCT00001766

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients

Phase 2

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 36

Registration Number: NCT00001474

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

Phase 1

Completed

Conditions: Chronic Granulomatous Disease

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00001765

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients

Phase 2

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 80

Registration Number: NCT00001357

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy